171 related articles for article (PubMed ID: 26903428)
1. Etonogestrel Implants in Adolescents: Experience, Satisfaction, and Continuation.
Obijuru L; Bumpus S; Auinger P; Baldwin CD
J Adolesc Health; 2016 Mar; 58(3):284-9. PubMed ID: 26903428
[TBL] [Abstract][Full Text] [Related]
2. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.
Ireland LD; Goyal V; Raker CA; Murray A; Allen RH
Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904
[TBL] [Abstract][Full Text] [Related]
3. Immediate postpartum etonogestrel implant: a contraception option with long-term continuation.
Wilson S; Tennant C; Sammel MD; Schreiber C
Contraception; 2014 Sep; 90(3):259-64. PubMed ID: 24993485
[TBL] [Abstract][Full Text] [Related]
4. Association of body mass index with removal of etonogestrel subdermal implant.
Casey PM; Long ME; Marnach ML; Fleming-Harvey J; Drozdowicz LB; Weaver AL
Contraception; 2013 Mar; 87(3):370-4. PubMed ID: 22959901
[TBL] [Abstract][Full Text] [Related]
5. Long-acting reversible contraception in adolescents: a systematic review and meta-analysis.
Diedrich JT; Klein DA; Peipert JF
Am J Obstet Gynecol; 2017 Apr; 216(4):364.e1-364.e12. PubMed ID: 28038902
[TBL] [Abstract][Full Text] [Related]
6. Management of etonogestrel subdermal implant-related bleeding.
Casey PM; Long ME; Drozdowicz LB; Marnach ML; Weaver AL
J Reprod Med; 2014; 59(5-6):306-12. PubMed ID: 24937974
[TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
Modesto W; Bahamondes MV; Bahamondes L
Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
[TBL] [Abstract][Full Text] [Related]
8. Bleeding related to etonogestrel subdermal implant in a US population.
Casey PM; Long ME; Marnach ML; Bury JE
Contraception; 2011 May; 83(5):426-30. PubMed ID: 21477684
[TBL] [Abstract][Full Text] [Related]
9. Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial.
Vieira CS; de Nadai MN; de Melo Pereira do Carmo LS; Braga GC; Infante BF; Stifani BM; Ferriani RA; Quintana SM
Contraception; 2019 Oct; 100(4):258-263. PubMed ID: 31145885
[TBL] [Abstract][Full Text] [Related]
10. Twelve-month discontinuation of etonogestrel implant in an outpatient pediatric setting.
Berlan E; Mizraji K; Bonny AE
Contraception; 2016 Jul; 94(1):81-6. PubMed ID: 26948183
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience and acceptability of the etonogestrel subdermal contraceptive implant.
Flores JB; Balderas ML; Bonilla MC; Vázquez-Estrada L
Int J Gynaecol Obstet; 2005 Sep; 90(3):228-33. PubMed ID: 16043175
[TBL] [Abstract][Full Text] [Related]
12. Insertion and 3-year follow-up experience of 372 etonogestrel subdermal contraceptive implants by family physicians in Granada, Spain.
Arribas-Mir L; Rueda-Lozano D; Agrela-Cardona M; Cedeño-Benavides T; Olvera-Porcel C; Bueno-Cavanillas A
Contraception; 2009 Nov; 80(5):457-62. PubMed ID: 19835720
[TBL] [Abstract][Full Text] [Related]
13. Continuation rates of the subdermal contraceptive Implanon(®) and associated influencing factors.
Teunissen AM; Grimm B; Roumen FJ
Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):15-21. PubMed ID: 24329119
[TBL] [Abstract][Full Text] [Related]
14. Continuation of the etonogestrel implant in women undergoing immediate postabortion placement.
Madden T; Eisenberg DL; Zhao Q; Buckel C; Secura GM; Peipert JF
Obstet Gynecol; 2012 Nov; 120(5):1053-9. PubMed ID: 23090522
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel.
Funk S; Miller MM; Mishell DR; Archer DF; Poindexter A; Schmidt J; Zampaglione E;
Contraception; 2005 May; 71(5):319-26. PubMed ID: 15854630
[TBL] [Abstract][Full Text] [Related]
16. ENG-releasing subdermal implants in postpartum teenagers - an open-label trial study protocol.
Barbieri MM; Juliato CRT; Bahamondes L; Surita FG
Reprod Health; 2020 Jun; 17(1):100. PubMed ID: 32576199
[TBL] [Abstract][Full Text] [Related]
17. A three-year comparative study of continuation rates, bleeding patterns and satisfaction in Australian women using a subdermal contraceptive implant or progestogen releasing-intrauterine system.
Weisberg E; Bateson D; McGeechan K; Mohapatra L
Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):5-14. PubMed ID: 24229367
[TBL] [Abstract][Full Text] [Related]
18. Intra-abortion contraception with etonogestrel subdermal implant.
Barros Pereira I; Carvalho RM; Graça LM
Eur J Obstet Gynecol Reprod Biol; 2015 Feb; 185():33-5. PubMed ID: 25522115
[TBL] [Abstract][Full Text] [Related]
19. One-year continuation of the etonogestrel contraceptive implant in women with postabortion or interval placement.
Mark A; Sonalkar S; Borgatta L
Contraception; 2013 Nov; 88(5):619-23. PubMed ID: 23790436
[TBL] [Abstract][Full Text] [Related]
20. Adolescent/Young Adult Long-Acting Reversible Contraception: Experience from a Multisite Adolescent Medicine Collaborative.
Pitts S; Milliren CE; Borzutzky C; Maslyanskaya S; Berg G; DiVasta AD
J Pediatr; 2022 Apr; 243():158-166. PubMed ID: 34952007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
